Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swedish Ziconotide Bolus Study
2010-018920-21Phase 2Terminated
- Sponsor
- Region Östergötland
- Start
- Feb 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ziconotide in chronic pain, sponsored by Region Östergötland. Primary endpoints: Primary efficacy outcome, VASPI pain intensity change and 1 more. Started Feb 2011; status: terminated.
02
Drugs
ziconotide
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2010-018920-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018920-21.